Comprehensive evaluation of compound Kushen injection combined with zoledronic acid in treating bone metastasis cancer pain based on meta-analysis and decision tree model
ObjectiveTo evaluate the safety, efficacy, and cost-effectiveness of combining Compound Kushen Injection (CKI) with zoledronic acid in the treatment of bone metastasis-induced cancer pain in malignant tumors.MethodsA comprehensive search of Chinese and English databases identified randomized control...
Saved in:
Main Authors: | Xi Zhao, Tianwei Meng, Kaiqiang Wang, Xi Yan, Yuqiang Liu, Xinghua Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pain Research |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpain.2024.1512925/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of denosumab vs. zoledronic acid in preventing skeletal-related events, including pain-related bone metastasis: a systematic review
by: I. Putu Eka Widyadharma, et al.
Published: (2024-10-01) -
PREVENTION OF COMPLICATIONS IN CASTRATE-REFRACTORY PROSTATE CANCER PATIENTS WITH BONE METASTASES
by: K. M. Nushko, et al.
Published: (2015-10-01) -
Annual Zoledronic Acid for the Treatment of Osteoporosis: A Randomized Controlled Trial
by: Asif Hussain, et al.
Published: (2023-01-01) -
Risk Factors for Acute Febrile Reaction after Zoledronic Acid Treatment for Primary Osteoporosis
by: WU Hongliang, et al.
Published: (2022-06-01) -
Impact of Bone-Modifying Agents on Post-Bone Metastasis Survival Across Cancer Types
by: Hironari Tamiya, et al.
Published: (2025-01-01)